Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enstilar foam in psoriasis patients on etanercept or adalimumab
NCT03827876Phase 4Recruiting
- Sponsor
- Psoriasis Treatment Center of Central New Jersey
- Start
- Jan 2019
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of calcipotriol in plaque psoriasis, sponsored by Psoriasis Treatment Center of Central New Jersey. Primary endpoint: Physician Global Assessment x Body Surface Area improvement at 16 weeks. Started Jan 2019; status: recruiting.
02
Drugs
calcipotriol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03827876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03827876.